In September 2023, the U.S. Centers for Disease Control and Prevention recommended everyone 6 months and older get an updated COVID-19 shot “to protect against the potentially serious outcomes of COVID-19 illness this fall and winter.”1 Admitting that any protection offered by the shots “declines over time,” they reiterated their common pandemic refrain that getting… Read More »
The video above features Collette Martin, a practicing nurse who testified before a Louisiana Health and Welfare Committee hearing December 6, 2021.1,2 Martin claims she and her colleagues have witnessed “terrifying” reactions to the COVID shots among children — including blood clots, heart attacks, encephalopathy and arrhythmias — yet their concerns are simply dismissed. Among… Read More »
Pfizer representatives will meet with federal health officials on Monday to discuss the possibility of a COVID-19 vaccine booster shot, a meeting that comes less than a week after the Biden administration reaffirmed its position that the two-shot regimen is enough for now. THE COVID-19 VARIANTS HEALTH OFFICIALS ARE WATCHING Present at the meeting will… Read More »
Maryland-based biotech company Novavax on Monday announced its experimental COVID-19 vaccine remained effective when coadministered with an approved flu shot. Researchers and drug makers are interested in studying coadministration and associated safety and efficacy, or giving multiple vaccines to a person during one visit, to ease logistics and help patients catch up on missed vaccinations,… Read More »
Business Health Loading the player… The U.S. is getting a third vaccine to prevent COVID-19, as the Food and Drug Administration on Saturday cleared a Johnson & Johnson shot that works with just one dose instead of two. Health experts are anxiously awaiting a one-and-done option to help speed vaccinations, as they race against a… Read More »
Johnson & Johnson plans to start testing its vaccine hopeful in children as young as 12. Meanwhile, Aspen Pharmacare entered a preliminary agreement to crank out J&J’s shot in South Africa. The UK’s drug regulator is investing £1.5 million in an artificial intelligence tool to track vaccine side effects. And India’s Bharat Biotech hopes to launch… Read More »
By Robert Preidt HealthDay Reporter WEDNESDAY, Jan. 9, 2019 (HealthDay News) — Many doctors may worry about giving their hospital patients a flu shot, but a new study suggests they can relax. “We know rates of inpatient flu vaccination are low, often due to physician concerns that the vaccine could complicate healing or delay hospital… Read More »